Literature DB >> 9121173

Pulmonary embolism associated with acute stroke.

E F Wijdicks1, J P Scott.   

Abstract

OBJECTIVE: To describe the circumstances surrounding pulmonary embolism associated with stroke, the prophylactic measures, and the outcome in affected patients.
MATERIAL AND METHODS: We studied pulmonary embolism in patients with acute stroke at Mayo Clinic Rochester during a 2-decade period. Medical records of 30 patients with pulmonary embolus after stroke were reviewed. Pulmonary embolus was diagnosed on the basis of pulmonary angiograms, high-or intermediate-probability ventilation-perfusion scans, or autopsy findings.
RESULTS: Sudden death occurred in 15 of 30 patients (50%) with pulmonary embolism. In the other 15 patients, pleuritic pain or dyspnea was a major initial symptom. Pulmonary embolism occurred from day 3 to day 120 (median time, day 20) after the ictus. Prophylaxis against deep venous thrombosis was noted in only 4 of 30 patients. Pulmonary embolism was associated with deep venous thrombosis diagnosed clinically or at autopsy in 11 patients, invariably in the paralyzed leg.
CONCLUSION: Pulmonary embolism after ischemic or hemorrhagic stroke may defy antemortem diagnosis in half of the affected patients. Pulmonary embolism in patients with acute stroke can be a cause of early mortality (during the first month after the ictus).

Entities:  

Mesh:

Year:  1997        PMID: 9121173     DOI: 10.4065/72.4.297

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  9 in total

Review 1.  Ischemic stroke: prevention of complications and secondary prevention.

Authors:  Marilyn M Rymer; Debbie Summers
Journal:  Mo Med       Date:  2010 Nov-Dec

2.  Assessment of Venous Thromboembolism Prophylaxis in Neurological Patients with Restricted Mobility - VTE-NEURO Study.

Authors:  Ovidiu Bajenaru; Florina Antochi; Rodica Balasa; Ioan Buraga; Sanda Patrichi; Mihaela Simu; Szatmari Szabolcs; Cristina Tiu; Cornelia Zaharia
Journal:  Maedica (Buchar)       Date:  2014-03

3.  Pulmonary complications after intracerebral hemorrhage.

Authors:  Boby Varkey Maramattom; Stephen Weigand; Megan Reinalda; Eelco F M Wijdicks; Edward M Manno
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

4.  Quality measures in stroke.

Authors:  Sharon N Poisson; S Andrew Josephson
Journal:  Neurohospitalist       Date:  2011-04

Review 5.  Prophylaxis of Venous Thrombosis in Neurocritical Care Patients: An Evidence-Based Guideline: A Statement for Healthcare Professionals from the Neurocritical Care Society.

Authors:  Paul Nyquist; Cynthia Bautista; Draga Jichici; Joseph Burns; Sanjeev Chhangani; Michele DeFilippis; Fernando D Goldenberg; Keri Kim; Xi Liu-DeRyke; William Mack; Kim Meyer
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

6.  Usefulness of the computed tomography venography for evaluation of leg edema including deep vein thrombosis in rehabilitation patients.

Authors:  Ji Hea Chang; Ho Jun Lee; Jae Hyun Kwon; Gi Hyeong Ryu; Heebong Moon; Changjae Kim; Ki Yeon Nam; Bum Sun Kwon
Journal:  Ann Rehabil Med       Date:  2014-12-24

7.  Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study.

Authors:  Ludvig B Rinde; Birgit Småbrekke; Ellisiv B Mathiesen; Maja-Lisa Løchen; Inger Njølstad; Erin M Hald; Tom Wilsgaard; Sigrid K Brækkan; John-Bjarne Hansen
Journal:  J Am Heart Assoc       Date:  2016-11-07       Impact factor: 5.501

8.  Cerebral Infarction with Pulmonary Thromboembolism Due to Immobilization.

Authors:  Yuzo Fujino; Tatsuya Kawasaki; Hirofumi Kawamata; Aiko Tamura; Kensuke Shiga; Hirokazu Oyamada
Journal:  Intern Med       Date:  2020-07-21       Impact factor: 1.271

9.  Association of chronic kidney disease with outcomes in acute stroke.

Authors:  Iong Man Tung; Raphae S Barlas; Priya Vart; Joao H Bettencourt-Silva; Allan B Clark; Kittisak Sawanyawisuth; Kannikar Kongbunkiat; Narongrit Kasemsap; Somsak Tiamkao; Phyo K Myint
Journal:  Acta Neurol Belg       Date:  2020-07-13       Impact factor: 2.396

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.